irritable bowel syndrome
Conditions
Interventions
Sponsors
Wangjing Hospital, Chinese Academy of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: To be admitted to the study, patients must meet all six of the following criteria: (1) The case met the above western diagnostic criteria; (2) Blood routine, urine routine, stool routine plus occult blood, biochemical and imaging tests to exclude other serious chronic diseases; (3) male and female patients aged 18 to 65 years; (4) Course of disease > 6 months; (5) No drug treatment was given within 4 weeks before enrollment; (6) Patients and their family members shall be informed and sign informed consent.
Exclusion criteria
Exclusion criteria: Patients meeting 1 or more of the following criteria should be excluded: (1) patients with severe liver and kidney function injury, severe heart, brain and lung diseases and severe mental diseases; (2) patients aged under 18 years or over 65 years; (3) during the observation period, taking other drugs, such as opioid antidiarrheal drugs or selective 5-HT reuptake inhibitors, affected the observation results; (4) Subjects are unwilling to participate in the test or have poor compliance; (5) pregnant or lactating women; (6) Patients with other body surface electrical stimulation or acupuncture therapy involved in the original treatment plan. (7) Patients with ear ulceration and other skin lesions. (8) Patients with known hypersensitivity to trimebutin maleate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of curative effect of abdominal pain symptom;Evaluation of overall disease efficacy;Serum inflammatory factor;IBS Quality of Life Questionnaire score; | — |
Countries
China
Contacts
Public ContactYiqing Zhang
Outcome results
None listed